Healthcare and Pharmaceuticals industry

Prescription Arthritis Medications Market 2020 By Manufacturers, Regions, Type And Application, Forecast To 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Prescription Arthritis Medications Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

High prevalence of arthritis is expected to propel growth of the global prescription arthritis medications market over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC)’s May 2019 report, an estimated 54.4 million US adults have diagnosed arthritis, which accounted for around 1 in 4 people in the U.S.

Increasing geriatric population is expected to offer lucrative growth opportunities for players in the global prescription arthritis medications market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Moreover, increasing adult arthritis visits is also expected to aid in growth of the market. For instance, according to the study, ‘Trends in office visits during which opioids were prescribed for adults with arthritis: United States, 2006‐2015’, published in Arthritis Care and Research in September 2020, the percentage of adult arthritis visits to office-based physicians increased significantly during 2006-2015, with the percentage of visits where opioids were prescribed also increasing during that time.

High arthritis expenditure is expected to hinder growth of the global prescription arthritis medications market. For instance, according to the study, “Mortality, disability, and healthcare expenditure of patients with seropositive rheumatoid arthritis in Korea: A nationwide population-based study”, published in the journal PLOS One in January 2019, the annual health expenditures were significantly larger for patients with rheumatoid arthritis than for controls. Moreover, availability of medications that do not require prescription is also expected to hinder growth of the market.

Major players operating in the global prescription arthritis medications market are focused on R&D to expand their product portfolio. For instance, in November 2020, The Janssen Pharmaceutical Companies of Johnson & Johnson announced data from two Phase 3 clinical trials, DISCOVER-1 and DISCOVER-2, which showed TREMFYA (guselkumab) improved fatigue in adult patients with active psoriatic arthritis (PsA).

Key Takeaways

  • High prevalence of arthritis is expected to propel growth of the global prescription arthritis medications market over the forecast period
  • Major players operating in the global prescription arthritis medications market are focused on R&D to expand their product portfolio. For instance, in November 2020, Novartis AG announced 12-week results from the first-of-its-kind Phase IIIb ULTIMATE randomized controlled trial, which demonstrated the significant treatment response of Cosentyx (secukinumab) on synovitis (joint lining inflammation) in psoriatic arthritis versus placebo.
  • Major players operating in the global prescription arthritis medications market include, Abbott Laboratories, Amgen, Boehringer Ingelheim, Horizon Pharma, Novartis AG, Pfizer, Inc., and Regeneron

The Prescription Arthritis Medications Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Prescription Arthritis Medications Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Abbott
  • Amgen
  • Boehringer Ingelheim
  • Horizon Pharma
  • Novartis
  • Pfizer
  • Regeneron
  • ...

By the Product Type, the market is primarily segmented into:

  • Oral
  • Topical

By Applications, the market is segmented into:

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Prescription Arthritis Medications Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Prescription Arthritis Medications Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Prescription Arthritis Medications Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Prescription Arthritis Medications Market

The Prescription Arthritis Medications Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Prescription Arthritis Medications Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

1 Study Coverage
1.1 Veterinary Infectious Diseases Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type
1.4.2 Antibiotics
1.4.3 Antiviral
1.4.4 Antifungal
1.4.5 Amebicides
1.4.6 Anthelmintics
1.5 Market by Application
1.5.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application
1.5.2 Swine
1.5.3 Chicken
1.5.4 Dog
1.5.5 Cat
1.5.6 Cow
1.5.7 Horse
1.5.8 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Veterinary Infectious Diseases Therapeutics Market Size
2.1.1 Global Veterinary Infectious Diseases Therapeutics Revenue 2014-2025
2.1.2 Global Veterinary Infectious Diseases Therapeutics Sales 2014-2025
2.2 Veterinary Infectious Diseases Therapeutics Growth Rate by Regions
2.2.1 Global Veterinary Infectious Diseases Therapeutics Sales by Regions
2.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Veterinary Infectious Diseases Therapeutics Sales by Manufacturers
3.1.1 Veterinary Infectious Diseases Therapeutics Sales by Manufacturers
3.1.2 Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers
3.2 Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers
3.2.1 Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Veterinary Infectious Diseases Therapeutics Revenue Share by Manufacturers (2014-2019)
3.3 Veterinary Infectious Diseases Therapeutics Price by Manufacturers
3.4 Veterinary Infectious Diseases Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Veterinary Infectious Diseases Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary Infectious Diseases Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Veterinary Infectious Diseases Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Type
4.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Type
4.3 Veterinary Infectious Diseases Therapeutics Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Veterinary Infectious Diseases Therapeutics Breakdown Data by Application

6 North America
6.1 North America Veterinary Infectious Diseases Therapeutics by Country
6.1.1 North America Veterinary Infectious Diseases Therapeutics Sales by Country
6.1.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Veterinary Infectious Diseases Therapeutics by Type
6.3 North America Veterinary Infectious Diseases Therapeutics by Application

7 Europe
7.1 Europe Veterinary Infectious Diseases Therapeutics by Country
7.1.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Country
7.1.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Veterinary Infectious Diseases Therapeutics by Type
7.3 Europe Veterinary Infectious Diseases Therapeutics by Application

8 Asia Pacific
8.1 Asia Pacific Veterinary Infectious Diseases Therapeutics by Region
8.1.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region
8.1.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Veterinary Infectious Diseases Therapeutics by Type
8.3 Asia Pacific Veterinary Infectious Diseases Therapeutics by Application

9 Central & South America
9.1 Central & South America Veterinary Infectious Diseases Therapeutics by Country
9.1.1 Central & South America Veterinary Infectious Diseases Therapeutics Sales by Country
9.1.2 Central & South America Veterinary Infectious Diseases Therapeutics Revenue by Country
9.1.3 Brazil
9.2 Central & South America Veterinary Infectious Diseases Therapeutics by Type
9.3 Central & South America Veterinary Infectious Diseases Therapeutics by Application

10 Middle East and Africa
10.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics by Country
10.1.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country
10.1.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics by Type
10.3 Middle East and Africa Veterinary Infectious Diseases Therapeutics by Application

11 Company Profiles
11.1 Elanco Animal Health
11.1.1 Elanco Animal Health Company Details
11.1.2 Company Business Overview
11.1.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
11.1.5 Elanco Animal Health Recent Development
11.2 Novartis Animal Health
11.2.1 Novartis Animal Health Company Details
11.2.2 Company Business Overview
11.2.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
11.2.5 Novartis Animal Health Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Veterinary Infectious Diseases Therapeutics Products Offered
11.3.5 Merck Recent Development
11.4 Pfizer Animal Health
11.4.1 Pfizer Animal Health Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
11.4.5 Pfizer Animal Health Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Company Business Overview
11.5.3 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sanofi Veterinary Infectious Diseases Therapeutics Products Offered
11.5.5 Sanofi Recent Development
11.6 Boehringer Ingelheim Vetmedica
11.6.1 Boehringer Ingelheim Vetmedica Company Details
11.6.2 Company Business Overview
11.6.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Products Offered
11.6.5 Boehringer Ingelheim Vetmedica Recent Development
11.7 Dechra Animal Health
11.7.1 Dechra Animal Health Company Details
11.7.2 Company Business Overview
11.7.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
11.7.5 Dechra Animal Health Recent Development
11.8 Ceva Sante Animale
11.8.1 Ceva Sante Animale Company Details
11.8.2 Company Business Overview
11.8.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Products Offered
11.8.5 Ceva Sante Animale Recent Development
11.9 Elanco Animal Health
11.9.1 Elanco Animal Health Company Details
11.9.2 Company Business Overview
11.9.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Products Offered
11.9.5 Elanco Animal Health Recent Development
11.10 Virbac
11.10.1 Virbac Company Details
11.10.2 Company Business Overview
11.10.3 Virbac Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Virbac Veterinary Infectious Diseases Therapeutics Products Offered
11.10.5 Virbac Recent Development

12 Future Forecast
12.1 Veterinary Infectious Diseases Therapeutics Market Forecast by Regions
12.1.1 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Regions 2019-2025
12.1.2 Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Regions 2019-2025
12.2 Veterinary Infectious Diseases Therapeutics Market Forecast by Type
12.2.1 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Type 2019-2025
12.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Type 2019-2025
12.3 Veterinary Infectious Diseases Therapeutics Market Forecast by Application
12.4 North America Veterinary Infectious Diseases Therapeutics Forecast
12.5 Europe Veterinary Infectious Diseases Therapeutics Forecast
12.6 Asia Pacific Veterinary Infectious Diseases Therapeutics Forecast
12.7 Central & South America Veterinary Infectious Diseases Therapeutics Forecast
12.8 Middle East and Africa Veterinary Infectious Diseases Therapeutics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Veterinary Infectious Diseases Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Table
List of Tables and Figures

Figure Veterinary Infectious Diseases Therapeutics Product Picture
Table Veterinary Infectious Diseases Therapeutics Market Segments
Table Key Manufacturers Veterinary Infectious Diseases Therapeutics Covered
Table Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type 2019-2025 (KG) & (Million US$)
Figure Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2018 & 2025
Figure Antibiotics Product Picture
Table Major Manufacturers of Antibiotics
Figure Antiviral Product Picture
Table Major Manufacturers of Antiviral
Figure Antifungal Product Picture
Table Major Manufacturers of Antifungal
Figure Amebicides Product Picture
Table Major Manufacturers of Amebicides
Figure Anthelmintics Product Picture
Table Major Manufacturers of Anthelmintics
Table Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application 2019-2025 (KG)
Figure Global Veterinary Infectious Diseases Therapeutics 4900 Sales Market Share by Application in 2018
Figure Swine
Figure Chicken
Figure Dog
Figure Cat
Figure Cow
Figure Horse
Figure Other
Figure Veterinary Infectious Diseases Therapeutics Report Years Considered
Figure Global Veterinary Infectious Diseases Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Veterinary Infectious Diseases Therapeutics Sales 2014-2025 (KG)
Table Global Veterinary Infectious Diseases Therapeutics Market Size by Regions 2014-2019 (KG) & (Million US$)
Table Global Veterinary Infectious Diseases Therapeutics Sales by Regions 2014-2019 (KG)
Table Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Regions 2014-2019
Figure Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Regions 2014-2019
Figure 2018 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Regions
Table Global Veterinary Infectious Diseases Therapeutics Revenue by Regions 2014-2019 (Million US$)
Table Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Regions
Table Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers (2014-2019) (KG)
Table Global Veterinary Infectious Diseases Therapeutics Sales Share by Manufacturers (2014-2019)
Figure Global Veterinary Infectious Diseases Therapeutics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2014-2019) (Million USD)
Table Veterinary Infectious Diseases Therapeutics Revenue Share by Manufacturers (2014-2019)
Figure Veterinary Infectious Diseases Therapeutics Value Share by Manufacturers in 2018
Table Key Manufacturers Veterinary Infectious Diseases Therapeutics Price (2014-2019) (USD/KG)
Table Veterinary Infectious Diseases Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Veterinary Infectious Diseases Therapeutics Product Type
Table Date of International Manufacturers Enter into Veterinary Infectious Diseases Therapeutics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Veterinary Infectious Diseases Therapeutics Sales by Type (2014-2019) (KG)
Table Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2014-2019)
Figure Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2014-2019)
Figure Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2018
Table Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2014-2019) (Million US$)
Table Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2014-2019)
Figure Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2014-2019)
Figure Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type in 2018
Table Veterinary Infectious Diseases Therapeutics Price by Type 2014-2019 (USD/KG)
Table Global Veterinary Infectious Diseases Therapeutics Sales by Application (2014-2019) (KG)
Table Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2014-2019)
Figure Global Sales Veterinary Infectious Diseases Therapeutics Market Share by Application (2014-2019)
Figure Global Sales Veterinary Infectious Diseases Therapeutics Market Share by Application in 2018
Figure North America Veterinary Infectious Diseases Therapeutics Sales Growth Rate 2014-2019 (KG)
Figure North America Veterinary Infectious Diseases Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Veterinary Infectious Diseases Therapeutics Sales by Country (2014-2019) (KG)
Table North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2014-2019)
Figure 2018 North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Country
Table North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2014-2019) (Million US$)
Table North America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2014-2019)
Figure 2018 North America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country
Figure United States Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure United States Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Canada Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Canada Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Mexico Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Veterinary Infectious Diseases Therapeutics Sales by Type (2014-2019) (KG)
Table North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2014-2019)
Figure 2018 North America Veterinary Infectious Diseases Therapeutics Market Share by Type
Table North America Veterinary Infectious Diseases Therapeutics Sales by Application (2014-2019) (KG)
Table North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2014-2019)
Figure 2018 North America Veterinary Infectious Diseases Therapeutics Market Share by Application
Figure Europe Veterinary Infectious Diseases Therapeutics Sales Growth Rate 2014-2019 (KG)
Figure Europe Veterinary Infectious Diseases Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2014-2019) (KG)
Table Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2014-2019)
Figure 2018 Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Country
Table Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2014-2019) (Million US$)
Table Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2014-2019)
Figure 2018 Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country
Figure Germany Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Germany Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure France Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure UK Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Italy Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Russia Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2014-2019) (KG)
Table Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2014-2019)
Figure 2018 Europe Veterinary Infectious Diseases Therapeutics Market Share by Type
Table Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2014-2019) (KG)
Table Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2014-2019)
Figure 2018 Europe Veterinary Infectious Diseases Therapeutics Market Share by Application
Figure Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Growth Rate 2014-2019 (KG)
Figure Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2014-2019) (KG)
Table Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Region
Table Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2014-2019) (Million US$)
Table Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country
Figure China Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure China Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Japan Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Korea Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure South Korea Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure India Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Australia Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Indonesia Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Thailand Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Malaysia Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Philippines Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Vietnam Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2014-2019) (KG)
Table Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2014-2019)
Figure 2018 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Share by Type
Table Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2014-2019) (KG)
Table Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2014-2019)
Figure 2018 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Share by Application
Figure Central & South America Veterinary Infectious Diseases Therapeutics Sales Growth Rate 2014-2019 (KG)
Figure Central & South America Veterinary Infectious Diseases Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Veterinary Infectious Diseases Therapeutics Sales by Country (2014-2019) (KG)
Table Central & South America Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2014-2019)
Figure 2018 Central & South America Veterinary Infectious Diseases Therapeutics Sales Market Share by Country
Table Central & South America Veterinary Infectious Diseases Therapeutics Revenue by Country (2014-2019) (Million US$)
Table Central & South America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2014-2019)
Figure 2018 Central & South America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country
Figure Brazil Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Brazil Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Veterinary Infectious Diseases Therapeutics Sales by Type (2014-2019) (KG)
Table Central & South America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2014-2019)
Figure 2018 Central & South America Veterinary Infectious Diseases Therapeutics Market Share by Type
Table Central & South America Veterinary Infectious Diseases Therapeutics Sales by Application (2014-2019) (KG)
Table Central & South America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2014-2019)
Figure 2018 Central & South America Veterinary Infectious Diseases Therapeutics Market Share by Application
Figure Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Growth Rate 2014-2019 (KG)
Figure Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2014-2019) (KG)
Table Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Country
Table Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2014-2019) (Million US$)
Table Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country
Figure Turkey Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Turkey Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure GCC Countries Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure GCC Countries Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure Egypt Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Veterinary Infectious Diseases Therapeutics Sales Growth Rate (2014-2019) (KG)
Figure South Africa Veterinary Infectious Diseases Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2014-2019) (KG)
Table Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2014-2019)
Figure 2018 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Share by Type
Table Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2014-2019) (KG)
Table Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2014-2019)
Figure 2018 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Share by Application
Table Elanco Animal Health Company Details
Table Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019)
Table Elanco Animal Health Recent Development

Table Novartis Animal Health Company Details
Table Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019)
Table Novartis Animal Health Recent Development

Table Merck Company Details
Table Merck Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019)
Table Merck Recent Development

Table Pfizer Animal Health Company Details
Table Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019)
Table Pfizer Animal Health Recent Development

Table Sanofi Company Details
Table Sanofi Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019)
Table Sanofi Recent Development

Table Boehringer Ingelheim Vetmedica Company Details
Table Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Vetmedica Recent Development

Table Dechra Animal Health Company Details
Table Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019)
Table Dechra Animal Health Recent Development

Table Ceva Sante Animale Company Details
Table Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019)
Table Ceva Sante Animale Recent Development

Table Elanco Animal Health Company Details
Table Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019)
Table Elanco Animal Health Recent Development

Table Virbac Company Details
Table Virbac Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019)
Table Virbac Recent Development

Table Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Regions 2019-2025 (KG)
Table Global Veterinary Infectious Diseases Therapeutics Sales Market Share Forecast by Regions 2019-2025
Table Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Veterinary Infectious Diseases Therapeutics Revenue Market Share Forecast by Regions 2019-2025
Table Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Type 2019-2025 (KG)
Table Global Veterinary Infectious Diseases Therapeutics Sales Market Share Forecast by Type 2019-2025
Table Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Type 2019-2025 (Million US$)
Table Global Veterinary Infectious Diseases Therapeutics Revenue Market Share Forecast by Type 2019-2025
Table Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Application 2019-2025 (KG)
Table Global Veterinary Infectious Diseases Therapeutics Sales Market Share Forecast by Application 2019-2025
Figure North America Veterinary Infectious Diseases Therapeutics Sales Growth Rate Forecast (2019-2025) (KG)
Figure North America Veterinary Infectious Diseases Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Veterinary Infectious Diseases Therapeutics Sales Growth Rate Forecast (2019-2025) (KG)
Figure Europe Veterinary Infectious Diseases Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Growth Rate Forecast (2019-2025) (KG)
Figure Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Veterinary Infectious Diseases Therapeutics Sales Growth Rate Forecast (2019-2025) (KG)
Figure Central & South America Veterinary Infectious Diseases Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Growth Rate Forecast (2019-2025) (KG)
Figure Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Table Market Risks
Figure Porter's Five Forces Analysis
Table Veterinary Infectious Diseases Therapeutics Value Chain
Table Veterinary Infectious Diseases Therapeutics Customers List
Figure Channels of Distribution
Table Veterinary Infectious Diseases Therapeutics Distributors List
Figure Distributors Profiles
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.